Adaptive Capital Partners is a Singapore-based, earlystage technology-focused venture capital firm established in 2022. We invest in high-conviction and disruptive technology startups with a predominant focus on (i) Healthtech / Medtech and (ii) SEA B2B tech-enabled companies while working with founders in many of their defining challenges with our team’s deep experience as an operator and research background. We believe that venture capital is not just about numbers. It is about how well you understand the startups and create value for them. We are here as enablers to support entrepreneurs in their exceptional journey.
Singapore, SG
Congratulations to the Biorithm's new appointment. We look forward to many fruitful chapters with Amrish Nair, Jenny Hoffmann, PhD and team to drive Biorithm's mission of forging new frontiers in women's health and pregnancy care journey forward.
Biorithm is excited to welcome Jenny Hoffmann, PhD as our CEO! For more information, please see the article. https://lnkd.in/edDrZ3Pz
Adaptive Capital Partners reposted this
How can new angel investors get started? Last week, I had the honour of sharing a panel with some wonderful women (Rosalind Tan, Adaptive Capital Partners; Amanda Cham, 500 Global; Kristine Phung & Hester, Epic Angels) at Epic Angels' quarterly mixer. Some things we talked about: 1. Deal sourcing: how do you find the best quality dealflow? Good quality dealflow doesn't sit around and wait to be discovered; put yourself out there, meet people from different circles, join different networks to get a good lay of the land. And while events and networks are a great way to expand your circles, curate which ones you attend or join so that it'll be the best use of your time and energy. 2. Reviewing pitches: how do you know what to look for? When you're just starting to invest, diving first into industries / verticals that you're familiar with is a good start. You'd know what works, what to look for, and even what some red flags are. Once you've formed better mental models on investments, diving into new industries would feel less daunting. And above all that you're optimising for, the most important is investor-founder fit. 3. Decision making: how do you decide to invest? Don't be afraid to ask questions to get clarity. There are no stupid questions! In doing so, as long as you're at ~80% conviction, that's good enough to cut the check. Leave the ~20% for (pleasant) surprises :) And misjudgement of deals and people do happen - we're only human. What's important is to learn from it to make better decisions in the future. I always love being in a room full of inspiring and ambitious women. Thanks Epic Angels for empowering women to do more and be more, and for having me and Hustle Fund be a tiny part of this mission 💕
“Excessive certainty is the enemy. Acknowledging your limitation is your friend. It keeps you from getting into trouble.” This statement highly correlates to the topic discussed during recent NextGens panel organized by PwC. With attendees from over 16 countries, the discussion topics though varied, it central around the theme of how rapid changes in technology and NextGen businesses coincides and if anything how NextGen embraces them while steering their businesses. Many thanks to PwC for organizing these 2 days-forum where many intellectual discussions where formed. Shi-Ying Lau 刘诗莹 Kexin Lim
Thank you HealthTEC.SG-Singapore Health Technologies Consortium and SGInnovate for inviting our Partner, Rosalind Tan (陈燕晴) to be on the panel recently. The questions raised by the audience in the Healthtech Startup and fundraising landscape in the current climate had been nothing short of inspiring. We are glad to see the full house turnout to the event with meaningful connections formed.
On 11 April afternoon, HealthTEC.SG-Singapore Health Technologies Consortium had the privilege of co-organizing “Healthtech Startup: Navigating the Path to Funding” together with SGInnovate! The event kicked off with an informative sharing by the moderator Mayank Gurnani, MD MBA MSc followed by an in depth panel discussion with experts in fundraising and investment (Chern Chet YongAlex Tan, Rosalind Tan (陈燕晴) and Andrew Wu). They provided some qualitative insights into the current environment and shared about the various sources available for startups to match with to ensure proper growth, particularly, the strategic partners they can liaise with for geographical segmentation. Furthermore, they reminded startups to be aware of potential regulatory challenges and risks when seeking funding. This was succeeded by individual pitches by 6 of our members (Cogniant, ONWARD Health Research,TIIM Healthcare, Digital Life Line, REVIVO BioSystems, Gaitmetrics) who shared on their techs and their potential in the industry to convince investors to pitch in. Our members shared more on the growth expectations for their companies and were given valuable feedback by our audience in the Q&A after their presentations. Finally, the event was wrapped up with a productive #networking session where investors and members interacted to create #meaningfulpartnerships. Though the event was focused on investments, various members of the sectors and industries participated in the event to allow for more #impactful connections to be made. We hope that our members and the industry members benefited from this event and shall strive to create more such opportunities. Mayank Gurnani, MD MBA MSc | Chern Chet Yong | 22Health Ventures | Alex Tan | ZICO Capital | ZICO Holdings | Rosalind Tan (陈燕晴) | Adaptive Capital Partners | Andrew Wu | Mesh Bio | Ali Asgar Bhagat | Gordon Xiong, Ph.D. | Eliza Ho | Sheam Kannan | Sriivatsav Narasa | Vanessa Phua | Jerry Lui | Neeraj Kothari | Martin| Keng Liang Cheng | Weijie Poh, PhD | Muhammad Azri Bin Razali | Massimo Alberti | Tuan-Tong Foo | Udi Shaked
We are excited of the collaboration between FIND Surgical Sciences and MEGIN, the global leader for MEG technology, a non-invasive, functional brain mapping solution for neurological conditions. FIND Surgical Sciences joined Adaptive’s portfolio of investments in late 2023. A spin out of Massachusetts General Hospital, FIND is working on pioneering platform aimed at improving surgical outcomes for Drug-Resistant Epilepsy patients. Click on the link below to find out more about the collaboration.
We are happy to announce the kickoff of our collaborative project with FIND Surgical Sciences! In this project, FIND Neuro will develop a platform to improve MEG utilization for pre-surgical evaluation. The solution encompasses 3 key components: (1) A multimodal cloud-based viewer, (2) A web-based dashboard for data management, and (3) Neurodynamic analysis tools for epileptic events detections and epileptogenic network reconstruction. We believe FIND’s solution will significantly improve the precision and effectiveness of pre-surgical evaluation, ultimately leading to better surgical patient outcomes. Read the press release to learn more about our new strategic partnership with FIND Neuro: https://lnkd.in/eibsWYYj #MEG #MEGIN #FINDNeuro #multimodal #presurgicalevaluation
We are extremely honored to be part of LaPasar’s impact journey to make a difference in moms & pops stores in Malaysia. 🙌 Two things on LaPasar to applaud for: 1. Capital Efficiency: They are a prime example of a startup that truly excel in this metric. The meticulously management of P&L, while achieving the high growth top line figure and healthy bottom line, is commendable. 2. Humility, honesty and hunger. These are the 3H values to describe LaPasar. The team continually keep their heads bow while chasing their aggressive target. Congrats team Lapasar! With strong leadership under Thinesh Kumar Asogan Noomi Fessler Lakshman Das Asogan and Dannis Raj David, and esteemed investors as @KWAP Malaysia Creador and Gobi Partners, we are excited on your journey ahead!
Ordinary people blessed with extraordinary opportunities. Amidst countless companies and talented founding teams, we've been entrusted to create an impact. We have a responsibility to give it our all and make FMCG distribution for General Trade the best version it can be. We are excited, humbled, anxious & optimistic about the road ahead. #teamLapasar
Join us for the next AWS Health/Biotech Coffee Club in Jakarta on Feb 22nd and Singapore on March 5th as our colleagues will be participating in the meet and greet sessions. Kudos to Dr Terence Tan, MBBS, MSc, GDFM, GDOM and his team for building a vibrant Healthtech/Biotech/Medtech community. David Liow Rosalind Tan (陈燕晴) Amazon Web Services (AWS)
We are Hiring - Digitizing and empowering clinics with Klinik Pintar to strengthen primary healthcare in Indonesia 🇮🇩
Join us at Health & Biotech Coffee Club! AHI Association of Healthtech Indonesia & Amazon Web Services (AWS) proudly present this inaugural event in Jakarta. Meet and network with leaders from healthcare and healthtech companies in Indonesia as well as Digital Transformation Office (DTO) Kemenkes We have an allstar line up for this event: Setiaji Setiaji Reza Pramono Dr Terence Tan, MBBS, MSc, GDFM, GDOM Brata Rafly Gregorius Bimantoro Hafidz Alhadi L. Levana Sani Leontius Adhika Pradhana Gunawan Susanto Curious about "What's Next After Digitization in the world of health and biotech ? Let's dive into the future together on February 22, 2024 starting at 3.30 pm, at AWS Jakarta Office. Register now at bit.ly/afterdigitization and unlock Casual connections, Good Coffee and Exclusive Benefits! Let's elevate our conversations over great company and good cup a coffee! See you there!
Maternal Health / Femtech has always been an area close to our heart. Despite its importance, investment in maternal health often receives inadequate attention and funding compared to other health issues. Addressing this gap requires increased awareness, political commitment, and financial resources to ensure that every woman has access to quality maternal healthcare. Adaptive is proud to announce news of our most recent investment into Biorithm, a co-led initiative between Adaptive Capital Partners and SEEDS Capital, the investment arm of Enterprise Singapore. We look forward to working with the team, led by Amrish Nair, to drive interconnected healthcare solutions for expectant mothers. Welcome to the family, Biorithm! #maternalhealth #femtech #remotemonitoring https://lnkd.in/gJmB2sNc
We are incredibly humbled to be invited to be part of Bloomberg New Economy Catalyst dinner last week; a recognition given to top 20 catalyst. This recognition is awarded to a global group of policymakers, entrepreneurs, scientists and visionaries whose remarkable contributions and ideas have helped create a more sustainable, inclusive and prosperous world. Oriana Papin-Zoghbi as 1 of the 20 catalysts, has been a visionary leader in the field of women’s health and diagnostics. Together with her team at AOA Dxa, they are developing the first non-invasive liquid biopsy test for early ovarian cancer detection. Data shows nearly 225,000 women globally are diagnosed with ovarian cancer annually, and over 50% of them will not survive. Ovarian cancer’s high fatality rate is largely attributed to late detection. The average time to diagnose ovarian cancer is 31 weeks even though 9 in 10 women experience symptoms early on. The overwhelming support from both strategic investors, clinicians and regulators has shown the remarkable affirmation on the good work AOA Dx is working on. We are proud to be a small part of this journey. Shi-Ying Lau 刘诗莹 Rosalind Tan (陈燕晴)
“Perhaps unicorn blindness or biasses is a more accurate assessment of the speculative nature and hype around the pursuit of unicorns.” “Recent macro environment triggers had the VC industry have a hard reset moment on reevaluating the solid fundamentals when it comes to private market investing” as shared by our Managing Partner Shi-Ying Lau 刘诗莹 during this week’s @Entrepreneurs Summit, sharing alongside Jamaludin Bujang (Managing Partner of Gobi Partners and Nizam Mohamed Nadzri (CEO of Malaysia Debt Ventures Berhad A bit shout out to NEXEA - Venture Capital, Angel Investors & Accelerator with MyDIGITAL Corporation, AFFIN Group and Digital News Asia for the overwhelming summit crowd with equally refreshing and energetic panel speakers.